SEC Form 4 · accession 0001553878-17-000015
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurie Keating
Officer — SVP, GC and Secretary
Period of report
May 30, 2017
Accepted (ET)
May 31, 2017 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 30, 2017 | P | 11,500 | $65.348 | A | 11,500 | D | |
| Common StockF1 | holding | — | — | — | 207 | I | By Managed Account |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person owns 207 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.